epilepsies Ovid Therapeutics OV935/TAK-935

Ovid Therapeutics starts ELEKTRA and ARCADE trials for rare epilepsies

Ovid Therapeutics has commenced two Phase ll ELEKTRA and ARCADE trials of OV935/TAK-935 for the treatment of paediatric patients with…